His primary scientific interests are in Neuroscience, Endocrinology, Internal medicine, Receptor and Spinal cord. His work deals with themes such as Agonist, Opioid peptide and Pharmacology, which intersect with Neuroscience. In his study, which falls under the umbrella issue of Endocrinology, Nucleus raphe magnus and Raphe is strongly linked to Neuropeptide.
His biological study spans a wide range of topics, including Endogeny and Premovement neuronal activity. His research in Spinal cord intersects with topics in Laterodorsal tegmental nucleus, Raphe nuclei and Brainstem. Biophysics is closely connected to Immunocytochemistry in his research, which is encompassed under the umbrella topic of Periaqueductal gray.
Neuroscience, Spinal cord, Endocrinology, Internal medicine and Serotonergic are his primary areas of study. His Neuroscience research is multidisciplinary, incorporating elements of Opioid receptor, Opioid and Postsynaptic potential. Martin W. Wessendorf has included themes like Nociception, Central nervous system, Anatomy, Brainstem and Substance P in his Spinal cord study.
His Substance P research incorporates themes from Neurotransmitter and Serotonin. His Endocrinology study combines topics from a wide range of disciplines, such as Neuropeptide, Receptor and Nucleus raphe magnus. His work on Inhibitory postsynaptic potential and Tyrosine hydroxylase as part of general Internal medicine study is frequently connected to Aromatase, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Martin W. Wessendorf focuses on Nociception, Pharmacology, Spinal cord, Dynorphin and Receptor. His studies in Nociception integrate themes in fields like Nerve injury, Neuropathic pain and Neuroscience. The concepts of his Neuroscience study are interwoven with issues in Membrane and Rostral ventromedial medulla.
His Pharmacology research includes elements of GABAB receptor, Neurotransmission, Dopamine and Metabotropic receptor. His Dynorphin research is multidisciplinary, relying on both Nociceptin receptor, Opioid receptor, κ-opioid receptor and Endogenous opioid. His study on Receptor is covered under Internal medicine.
His primary areas of study are Nociception, Pharmacology, Internal medicine, Receptor and Dynorphin. His Nociception research incorporates elements of Spinal cord, Neuroscience, Brainstem and Medulla oblongata. Martin W. Wessendorf has researched Pharmacology in several fields, including Glutamatergic, Inhibitory postsynaptic potential and Neurotransmission.
His Internal medicine study frequently draws connections to adjacent fields such as Endocrinology. His research in the fields of κ-opioid receptor and Opioid receptor overlaps with other disciplines such as Estrogen receptor beta and Estrogen receptor alpha.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord
Ulf Arvidsson;Maureen Riedl;Sumita Chakrabarti;Jang Hern Lee.
The Journal of Neuroscience (1995)
Reduction of Lipofuscin-like Autofluorescence in Fluorescently Labeled Tissue
Stephen A. Schnell;William A. Staines;Martin W. Wessendorf.
Journal of Histochemistry and Cytochemistry (1999)
Characterization of an immunofluorescence technique for the demonstration of coexisting neurotransmitters within nerve fibers and terminals.
Martin W. Wessendorf;Robert P. Elde.
Journal of Histochemistry and Cytochemistry (1985)
delta-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin
Ulf Arvidsson;Robert J. Dado;Maureen Riedl;Jang Hern Lee.
The Journal of Neuroscience (1995)
Transneuronal labeling of CNS neuropeptide and monoamine neurons after pseudorabies virus injections into the stellate ganglion
A.S.P. Jansen;M.W. Wessendorf;A.D. Loewy.
Brain Research (1995)
A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids
D.L Cameron;M.W Wessendorf;J.T Williams.
Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2.
Laura Stone;Carolyn Fairbanks;Tinna Laughlin;H Nguyen.
Evidence for co-existence of thyrotropin-releasing hormone, substance P and serotonin in ventral medullary neurons that project to the intermediolateral cell column in the rat
C.A. Sasek;M.W. Wessendorf;C.J. Helke.
The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids
U Arvidsson;M Riedl;S Chakrabarti;L Vulchanova.
Proceedings of the National Academy of Sciences of the United States of America (1995)
Relationship of μ‐ and δ‐opioid receptors to GABAergic neurons in the central nervous system, including antinociceptive brainstem circuits
Alexander E. Kalyuzhny;Martin W. Wessendorf.
The Journal of Comparative Neurology (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: